Results 101 to 110 of about 13,407 (237)
, 2008 peer reviewedIvabradine (Procoralan), a new If inhibitor which acts specifically and in a dose-dependent manner on the pacemaker activity of the sinoatrial node, is a pure heart rate lowering agent.
LANCELLOTTI, Patrizio
core
IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
Российский кардиологический журнал, 2018 The article is focused on the data concerning the influence of ivabradine on myocardial electrophysiology in experimental and clinical studies. It is shown that ivabradine decreases ventricular rate in chronic atrial fibrillation, and prevents the ...
E. I. Tarlovskaya
doaj +1 more source
Simulated Clinical Trias: some design issues [PDF]
, 2010 Simulation is widely used to investigate real-world systems in a large number of fields, including clinical trials for drug development, since real trials are costly, frequently fail and may lead to serious side effects.
Giovagnoli, Alessandra +1 more
core +1 more source
The clinical and economic efficiency of treatment in patients with chronic heart failure
КардиоСоматика, 2013 Objective: to study the clinical and economic benefits of adding ivabradine to standard therapy for chronic heart failure (CHF). Subjects and methods.
E. I Tarlovskaya, S. V Malchikova
doaj
Rambam Maimonides Medical Journal, 2015 Background: Postural tachycardia syndrome (POTS) is a common form of chronic orthostatic intolerance. The remarkable increase in heart rate (HR) upon standing is the hallmark of this syndrome.
Merav Barzilai, Giris Jacob
doaj +1 more source
Significado pronóstico y evolución a largo plazo de la frecuencia cardiaca en los pacientes con trasplante cardiaco [PDF]
, 2015 [Abstract] Introduction and objectives. The aim of the present study was to examine the prognostic significance of heart rate and its trend in heart transplantation. Methods.
Barge-Caballero, Eduardo +9 more
core +2 more sources
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. [PDF]
, 2015 AimsThe mechanistic basis of the symptoms and signs of myocardial ischaemia in patients without obstructive coronary artery disease (CAD) and evidence of coronary microvascular dysfunction (CMD) is unclear.
Anderson, R David +15 more
core +1 more source
Erratum to: Beta-Blockers and Ivabradine in Chronic Heart Failure: From Clinical Trials to Clinical Practice [PDF]
, 2014 Antonino Di Franco +6 more
openalex +1 more source
Российский кардиологический журнал, 2018 The review is focused on the role of ivabradine in percutaneous coronary intervention (PCI) and coronary bypass grafting (CBG) in coronary heart disease patients (CHD) with stable angina.
D. M. Aronov, M. G. Bubnova
doaj +1 more source